Abstract:Retinoic X receptor (RXR) is a master nuclear receptor in the processes of cell development and homeostasis. Unliganded RXR exists in an autorepressed tetramer, and agonists can induce RXR dimerization and coactivator recruitment for activation. However, the molecular mechanisms involving the corepressor recruitment and antagonist-mediated repression of RXR are still elusive. Here we report the crystal structure of RXRα ligand-binding domain (LBD) complexed with silencing mediator for retinoid and thyroid hormone receptors (SMRT) corepressor motif. As the first structural report on the unliganded nuclear receptor bound to the corepressor motif, RXRαLBD-SMRT exhibits a significant structural rearrangement, compared with apoRXRαLBD tetramer. To elucidate further the molecular determinants for RXR repression by its antagonist, we also determine the crystal structure of RXRαLBD-SMRT complexed with the identified antagonist rhein. In the structure, two rhein molecules and two SMRT peptides are in the RXRαLBD tetramer, different from the case in RXRαLBD-SMRT structure, where four SMRT peptides bind to RXRαLBD tetramer. It seems that rhein induces a displacement of SMRT motif by activation function 2 (AF-2) motif binding to the receptor. Combining our current work with the published results, structural superposition of RXRαLBDs in different states reveals that RXR uses an overlapped binding site for coactivator, corepressor, and AF-2 motifs, whereas the AF-2 motif adopts different conformations for agonist or antagonist interaction and coactivator or corepressor recruitment. Taken together, we thus propose a molecular model of RXR repression on the tetramer.

Structural Basis of the Farnesoid X Receptor/retinoid X Receptor Heterodimer on Inverted Repeat DNA

Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR

Ligand Binding and Heterodimerization with Retinoid X Receptor Α (rxrα) Induce Farnesoid X Receptor (FXR) Conformational Changes Affecting Coactivator Binding

Structural Basis for Retinoic X Receptor Repression on the Tetramer

Farnesoid X Receptor (FXR): Structures and Ligands.

Design, synthesis and biological evaluations of novel farnesoid X receptor (FXR) agonists

The farnesoid X receptor activates transcription independently of RXR at non-canonical response elements

STRUCTURAL BASIS FOR BILE ACID BINDING AND ACTIVATION OF THE NUCLEAR RECEPTOR FXR

FXR: structures, biology, and drug development for NASH and fibrosis diseases

Asymmetric binding of coactivator SRC1 to FXR-RXR and allosteric communication within the complex

Genome-wide Binding and Transcriptome Analysis of Human Farnesoid X Receptor in Primary Human Hepatocytes.

[Progress in the Ligands and Their Complex Structures of Farnesoid X Receptor].

Simulations reveal unique roles for the FXR hinge in the FXR-RXR nuclear receptor heterodimer

Retinoid X Receptor Heterodimers in Hepatic Function: Structural Insights and Therapeutic Potential

Recognition of LXXLL by ligand binding domain of the Farnesoid X receptor in molecular dynamics simulation

Progression in the study on roles of farnesoid X receptor

[On the Bile Acid Receptor FXR].

Role of Farnesoid X Receptor in Regulating Lipid Metabolism

Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer

Discovery of farnesoid X receptor and its role in bile acid metabolism